| __timestamp | Pharming Group N.V. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 21595165 | 580006000 |
| Thursday, January 1, 2015 | 6590427 | 676585000 |
| Friday, January 1, 2016 | 11768542 | 778966000 |
| Sunday, January 1, 2017 | 92587038 | 671251000 |
| Monday, January 1, 2018 | 129203843 | 463508000 |
| Tuesday, January 1, 2019 | 165412447 | 445724000 |
| Wednesday, January 1, 2020 | 203056430 | 399725000 |
| Friday, January 1, 2021 | 169670071 | 296656000 |
| Saturday, January 1, 2022 | 188060000 | 293122000 |
| Sunday, January 1, 2023 | 220104000 | 268323000 |
| Monday, January 1, 2024 | 304979000 |
Igniting the spark of knowledge
In the competitive landscape of the pharmaceutical industry, understanding financial performance is crucial. This analysis delves into the gross profit trends of Pharming Group N.V. and Taro Pharmaceutical Industries Ltd. over the past decade.
Pharming Group N.V. has shown a remarkable upward trajectory in gross profit, growing from a modest base in 2014 to a peak in 2023. The company experienced a significant surge in 2017, with profits increasing by over 700% compared to 2014. This growth reflects strategic advancements and successful product launches.
Conversely, Taro Pharmaceutical Industries Ltd. started with a robust gross profit in 2014, but faced a gradual decline, dropping by approximately 54% by 2023. Despite this, Taro remains a formidable player, consistently outperforming Pharming in absolute terms.
This comparative analysis highlights the dynamic nature of the pharmaceutical sector, where strategic decisions and market conditions can significantly impact financial outcomes.
Gross Profit Analysis: Comparing Novo Nordisk A/S and Pharming Group N.V.
Amgen Inc. vs Pharming Group N.V.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs Taro Pharmaceutical Industries Ltd.
Gross Profit Comparison: Vertex Pharmaceuticals Incorporated and Pharming Group N.V. Trends
Genmab A/S vs Pharming Group N.V.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Genmab A/S and Taro Pharmaceutical Industries Ltd. Trends
Viatris Inc. and Pharming Group N.V.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Halozyme Therapeutics, Inc. and Pharming Group N.V.
Gross Profit Analysis: Comparing Pharming Group N.V. and Amneal Pharmaceuticals, Inc.
Gross Profit Comparison: Pharming Group N.V. and Ligand Pharmaceuticals Incorporated Trends
Key Insights on Gross Profit: Bausch Health Companies Inc. vs Taro Pharmaceutical Industries Ltd.
Gross Profit Analysis: Comparing Taro Pharmaceutical Industries Ltd. and MiMedx Group, Inc.